Prospective Study of Maternal Mid-pregnancy 25-hydroxyvitamin D Level and Early Childhood Respiratory Disorders
Version of Record online: 20 AUG 2013
© 2013 John Wiley & Sons Ltd
Paediatric and Perinatal Epidemiology
Volume 27, Issue 6, pages 532–541, November 2013
How to Cite
Magnus, M. C., Stene, L. C., Håberg, S. E., Nafstad, P., Stigum, H., London, S. J. and Nystad, W. (2013), Prospective Study of Maternal Mid-pregnancy 25-hydroxyvitamin D Level and Early Childhood Respiratory Disorders. Paediatric and Perinatal Epidemiology, 27: 532–541. doi: 10.1111/ppe.12080
- Issue online: 17 OCT 2013
- Version of Record online: 20 AUG 2013
- NIH. Grant Numbers: ZIAES049019, UO1 NS 047537-01, UO1 NS 047537-06A1
- Norwegian Research Council/FUGE. Grant Number: 151918/S10
- Norwegian Extra-Foundation for Health and Rehabilitation. Grant Number: 2011.2.0218
Vol. 28, Issue 3, 276, Version of Record online: 3 APR 2014
Table S1. Comparing maternal and child characteristics of eligible subjects to random sample with 25-hydroxyvitamin D measured.
Table S2. Overview of previous studies of prenatal 25-hydroxyvitamin D (25(OH)D)levels, measured in the mother during pregnancy or cord blood, and development of respiratory tract infections.
Table S3. Overview of previous studies of prenatal 25-hydroxyvitamin D (25(OH)D) levels, measured in the mother during pregnancy or cord blood, and development of asthma.
Table S4. Comparing random sample of singleton children with maternal 25(OH)D measurements available by follow-up information available (n = 2375).
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.